Market Overview

UPDATE: Hilliard Lyons Initiates Cerner with Long-Term Buy on Technological Competitive Advantage

Related CERN
Baird Upgrades Cerner To Outperform
Benzinga's Top Upgrades
Tech IPO Inovalon Sees Big Growth, Carves First Base (Investor's Business Daily)

In a report published Monday, Hilliard Lyons analyst Stephen Turner initiated coverage on Cerner Corporation (NASDAQ: CERN) with a Long-Term Buy rating and $58.00 price target.

In the report, Hilliard Lyons noted, “We believe Cerner has a technological competitive advantage due to the company's sole focus on health care information technology, and its product offering size and scale within the industry. Through this competitive advantage along with government mandates and positive industry trends Cerner has the potential to gain market share, in our opinion. New growth trends beyond Cerner's core Electronic Health Record (EHR) system, Millennium, include physician practice management solutions, population health management and revenue cycle management software & services.”

Cerner Corporation closed on Friday at $47.37.

Latest Ratings for CERN

Mar 2015BairdUpgradesNeutralOutperform
Mar 2015RBC CapitalMaintainsOutperform
Mar 2015Topeka CapitalDowngradesBuyHold

View More Analyst Ratings for CERN
View the Latest Analyst Ratings

Posted-In: Hilliard Lyons Stephen TurnerAnalyst Color Initiation Analyst Ratings


Related Articles (CERN)

Around the Web, We're Loving...